Since the infectious rat polyarthritis strain belonging to mycoplasma (previously named PPLO) was isolated by Findlay, Mackenzie, Mac Callum, and Klieneberger (1939) , several attempts have been made to study their possible role in arthritis in man. Most of the results have been discouraging (Sabin and Johnson, 1940; Barnett, Balduzzi, Vaughan, and Morgan, 1966) , but a few positive findings were published in the early literature (Swift and Brown, 1939; Dienes, Ropes, Smith, Madoff, and Bauer, 1948; Butas, 1957; Kuzell and Mankle, 1960) .
In the 1960s, both Jonsson (1961) and Arai, Ishikawa, and Hotta (1964) isolated mycoplasma directly on cell-free media from patients with polyarthritis, but made no attempt to distinguish them from L-phase organisms. Bartholomew and Himes (1964) and Bartholomew (1965) obtained his isolations of mycoplasma from rheumatoid arthritis, lupus erythematosus, and Reiter's syndrome after preliminary passage in tissue cultures. Highton, Caughey, Berkley, and Middleston (1966) isolated mycoplasma in a case of rheumatoid arthritis with a later increasing rheumatoid factor titre and progressive disease. Fahlberg, Moor, Redmond, and Brewer (1966) obtained mycoplasma from synovial tissues or fluids in 22 of 24 patients with rheumatoid arthritis. Williams (1968) found a mycoplasma serologically related to Mycoplasmafermentans in 40 per cent. of ninety synovial fluids from cases of active rheumatoid arthritis. His control series consisted of 26 cases, mainly of osteoarthrosis. From this group five mycoplasmas were isloated, one isolate being related to M. fermentans. In order to separate mycoplasma from other materials present in the specimen, Williams (1968) used a sucrose density gradient.
Using cell-free media, we obtained in 1964 two strains related to Mycoplasma hominis type 2 (at present named Mycoplasma arthritidis) from one synovium and one joint fluid from two patients with definite Waaler-Rose-positive rheumatoid arthritis. A third strain was isolated from a scalene lymph node from a patient with an 8-year history of collagen disease who 3 years later developed a fatal myeloid leukaemia. A few patients with rheumatoid arthritis possessed antibodies against one of the strains isolated (Jansson and Wager, 1965, 1967) . Further studies are reported in this paper.
Material
In 1966 and 1967 33 specimens ofjoint fluid were studied; 31 patients were seen at a Rheumatism Care Office in Helsinki, one was upder treatment at the Third Department of Medicine, University of Helsinki, and one, a boy with juvenile rheumatoid arthritis, was treated at Aurora Hospital. All the cases were diagnosed as possible or definite rheumatoid arthritis in an acute phase. The patients had not received gold salts or tetracycline therapy for several weeks before the examination. Twelve specimens of synovium from patients with traumatic joint lesions and under treatment in the Invalid Foundation Hospital were studied as controls.
Methods

ISOLATION TECHNIQUE
This has been reported before (Jansson and Wager, 1967) . In short, the medium used was Bacto PPLO agar and enrichment broth supplemented with 20 per cent. pooled inactivated human serum, 2-5 per cent. yeast extract, and 20yg per ml. of DNA. 500 units penicillin per ml. and thallium acetate was added to a final concentration of 1: 2000. The pH of the medium was adjusted to 7 * 8. Later Bacto brain heart infusion broth and agar were used for subcultures and the broth was further enriched with egg yolk pasteurized at + 60°C. for 50 min. and added in amounts of 0n 1 to 10 ml. of broth medium.
The tissue specimens with some broth added were crushed in a mortar. Then a loopful of this mixture or 0 5 ml. of undiluted synovial fluid was inoculated into 10 ml. of enriched PPLO broth. The broth cultures were incubated at + 37°C. and subcultures were made on solid media after 3, 6, and 10 days, inoculating 0 1 ml. on small Petri dishes 5 cm. in diameter. The agar plates were incubated under aerobic and anaerobic conditions at +37°C. for 10 days. The main series and the controls were treated similarly.
STUDIES IN EMBRYONATED HENS EGGS
All the specimens were also inoculated into the yolk sacs of 6 to 8-day-old embryonated hens eggs. 0-25 ml. joint fluid or a 20 per cent. suspension of synovium were inoculated into four eggs, which were incubated at + 37°C. and candled every day. Those still living 10 days after inoculation were killed by chilling. The yolk sacs were harvested, ground, and prepared as 50 per cent. suspensions in PPLO broth. Three or four blind passages were done inoculating 0-25 ml. of these suspensions again into four eggs. The suspensions were tested for sterility by culturing on blood agar plates which were incubated under aerobic and anaerobic conditions. 0 1 ml. of the yolk sac suspensions was inoculated into enriched PPLO broth and subcultures made as before.
BIOCHEMICAL TESTS These were performed as described by Lemcke and Leach (1968) , except that brain heart infusion broth was used instead of PPLO broth. Also the arginine-containing medium was further enriched with cholesterol according to the method of Taylor-Robinson, Somerson, Turner, and Chanock (1963) .
PREPARATION OF HYPERIMMUNE SERA
The origin of the mycoplasma strains, the antigen preparation, and the immunization procedure have been described before (Jansson and Wager, 1967) . Antisera against three isolates (32-M, 52-M, and 56-M) were prepared with antigens cultivated in rabbit infusion broth enriched with 5 per cent. rabbit serun. Antisera against the other eight isolates were prepared with antigens grown in enriched brain heart infusion broth with 1 -3 ml. pasteurized egg yolk per 350 ml. broth and incubated for 15 to 20 days. Also a 100-fold concentrated antigen was used for intravenous injections.
GROWTH INHIBITION TEST
This was done according to the method of Clyde (1964) .
ANTIBODY STUDIES
The antigens for the complement-fixation (CF) test were prepared as described earlier (Jansson, 1964) , but without phenol treatment. The macro-CF test was performed as previously reported (Jansson, Wager, Stenstrom, Klemola, and Forssell, 1964) . The indirect haemagglutination (IHA) technique described by other workers for mycoplasma antibody studies was used with fresh, tannic acid-treated erythrocytes (Dowdle and Robinson, 1964; Taylor-Robinson, Canchola, Fox, and Chanock, 1964) . The metabolic inhibition (MI) tests were performed according to the method of Purcell, Taylor-Robinson, Wong, and Chanock (1966) and Taylor-Robinson, Purcell, Wong, and Chanock (1966) .
Results
Isolation studies 33 specimens of joint fluid were examined. All the specimens were inoculated 1 to 3 hours after they had been taken. A mycoplasma was directly isolated from four joint fluid specimens on cell-free media (strains 32-M, 52-M, 56-M, 120-M; seeTable). After primary inoculation into embryonated eggs, seven more mycoplasma strains were cultivated. Altogether, eleven strains were isolated from 33 patients. Twelve synovial specimens from patients with traumatic joint lesions were negative for mycoplasma. They were also passed through embryonated hens eggs.
Figs 1 to 6 illustrate the microscopical appearance of certain isolates. High magnification (x 1,000) and staining with Dienes stain in situ reveals the small pleomorphic granules of which each colony consists.
All the isolates showed the following features: (i) They did not convert into bacteria when penicillin and thallium acetate were omitted.
(ii) They required sterol for their growth.
(iii) On primary isolation all the strains grew better in an anaerobic milieu and rather slowly, in 7 to 10 days. arthritidis, M. pulmonis, and M. gallinarum. They were also examined against a strain (20-P) isolated from rheumatoid arthritis in 1964 (Jansson and Wager, 1967 (Jansson and Wager 1965, 1967) , we examined in 1965 specimens of joint fluid and synovium from 134 patients with rheumatoid arthritis. The cultivation method was that already described (Jansson and Wager, 1967) , except that five to six blind passages were done in broth with 1 week's interval. Micro-organisms suspected of being mycoplasma were obtained from 109 patients. Because of their poor growth and the lack of special microscopical equipment, their exact nature could not be verified at that time. Later, with these difficulties overcome, we were able to isolate mycoplasma directly on cell-free media from several patients with rheumatoid arthritis (Unpublished data). It has not been possible for us to identify our isolates with some of the recognized human mycoplasma species. It is not impossible that new human mycoplasma species or types will be found.
Our isolates seem to be pathogenic for mice. When the eleven strains were injected intraperitoneally into white mice weighing 9 to 12 g., five isolates (28-M, 32-M, 34-M, 35-M, and 131-M) killed one, two, or all three mice used for every strain in 5 to 10 days.
An interesting feature of our studies is the observation that some patients possessed antibodies against one isolate. We have recently carried out studies by IHA technique using as antigen another isolate from rheumatoid arthritis, strain 176-M. Out of 113 Waaler-Rose-positive sera, 38 showed antibodies in a titre of > 1/8, usually low. Six cases had a titre of > 1/128. Summary Specimens of joint fluid were examined from 33 patients diagnosed as cases of possible or definite rheumatoid arthritis in an acute phase. A mycoplasma was isolated directly on cell-free media from four patients. After preliminary passage into the yolk sacs of 6 to 8-day-old embryonated hens eggs, seven more strains were cultured. Twelve synovial specimens from patients with traumatic joint lesions were negative for mycoplasma. 
